Mingzhu Yin

Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer.

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer.

Journal: The Journal of clinical investigation

Published: February 24, 2016

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.

Journal: Journal of Cancer

Published: January 25, 2016

CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.

CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: November 20, 2014

MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.

MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: October 27, 2014

A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients.

A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients.

Journal: Molecular bioSystems

Published: May 29, 2014

Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.

Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.

Journal: Journal of proteome research

Published: November 21, 2012

Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients: a prospective cohort study.

Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients: a prospective cohort study.

Journal: PloS one

Published: August 27, 2012

Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.

Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 31, 2012

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 24, 2011

Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.

Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 17, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026